Univest
Univest
  • Markets

Vijaya Diagnostic Centre Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook

  • October 9, 2026
  • Posted by: Ankit Jaiswal
  • Category: Market
No Comments
Vijaya Diagnostic Centre Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook

CMP Rs 1,430.60 (9 Oct 2026). 52W range Rs 848.00 to Rs 1,593.60. PE 78.24. 2027 base Rs 1,664, bull Rs 1,726.

Quick Answer

The Vijaya Diagnostic Centre share price forecast for 2027 centres on a conservative case of Rs 1,602, a base case of Rs 1,664 and a bull case of Rs 1,726, against a current price of Rs 1,430.60. These targets scale today’s price by reported EPS growth at a constant PE multiple, so they rest on earnings the company has already delivered, not on broker forecasts. The base case implies 16.3% upside from today’s price. The daily technical setup reads mildly bearish.

Vijaya Diagnostic Centre share price prediction 2027 comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 1,430.60 on NSE as of 9 October 2026, 10.2% below its 52-week high of Rs 1,593.60, after the company reported net profit of Rs 172.98 crore for FY26.

This Vijaya Diagnostic Centre stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Vijaya Diagnostic Centre Share Price Today and Key Data
  • What Is the Vijaya Diagnostic Centre Share Price Prediction for 2027?
  • Vijaya Diagnostic Centre Share Price Forecast: What Has to Go Right by 2027
    • Conservative Case for the Vijaya Diagnostic Centre Share Price Target: Rs 1,602
    • Base Case for the Vijaya Diagnostic Centre Share Price Target: Rs 1,664
    • Bull Case for the Vijaya Diagnostic Centre Share Price Target: Rs 1,726
  • Vijaya Diagnostic Centre Financial Performance: Revenue, Profit and Margins
  • Is Vijaya Diagnostic Centre Overvalued or Undervalued Right Now?
  • Vijaya Diagnostic Centre Stock Analysis: Technical Outlook
  • Vijaya Diagnostic Centre Shareholding Pattern
  • Key Risks to the Vijaya Diagnostic Centre Share Price Target for 2027
    • Earnings and Margin Risk
    • Size and Liquidity Risk
    • Balance Sheet Risk
    • Technical Risk
  • Conclusion
  • Frequently Asked Questions on Vijaya Diagnostic Centre Share Price Prediction 2027
    • What is the Vijaya Diagnostic Centre share price target for 2027?
    • What is the Vijaya Diagnostic Centre share price today?
    • Is Vijaya Diagnostic Centre a good stock to buy for 2027?
    • Can Vijaya Diagnostic Centre stock reach Rs 1,726 in 2027?
    • What are the support and resistance levels for Vijaya Diagnostic Centre?
    • What are the main risks for Vijaya Diagnostic Centre stock in 2027?
    • How is the Vijaya Diagnostic Centre target price for 2027 calculated?

Vijaya Diagnostic Centre Share Price Today and Key Data

The Vijaya Diagnostic Centre share price today is Rs 1,430.60 on NSE, down 0.03% on the day. The market capitalisation stands at Rs 14,666 crore. Over the past year the price has risen 45.8% from Rs 981.40. Every Vijaya Diagnostic Centre stock forecast figure below starts from this price.

Metric Value
Company Vijaya Diagnostic Centre (VIJAYA)
Current Price Rs 1,430.60
52-Week High Rs 1,593.60 (23 September 2026)
52-Week Low Rs 848.00 (30 March 2026)
Market Cap Rs 14,666 crore
PE Ratio 78.24
Industry PE 62.79
PB Ratio 15.32
EPS (TTM) Rs 18.20
Return on Equity 18.07%
Debt to Equity 0.44
Dividend Yield 0.14%
Book Value per Share Rs 92.93

What Is the Vijaya Diagnostic Centre Share Price Prediction for 2027?

The Vijaya Diagnostic Centre share price prediction for 2027 is a conservative case of Rs 1,602, a base case of Rs 1,664 and a bull case of Rs 1,726. Against Rs 1,430.60, these imply 12.0% upside, 16.3% upside and 20.6% upside. They are model scenarios built from reported EPS growth, not broker targets.

Scenario EPS Growth Basis EPS Estimate PE Multiple Implied Value Upside vs Current Price
Conservative Case Lower of FY26 growth (20.6%) and 4-year CAGR (11.9%) Rs 20.37 (+11.9%) Unchanged from today (price to EPS ratio kept constant) Rs 1,602 +12.0%
Base Case Average of the two Rs 21.16 (+16.3%) Unchanged from today (price to EPS ratio kept constant) Rs 1,664 +16.3%
Bull Case Higher of the two Rs 21.95 (+20.6%) Unchanged from today (price to EPS ratio kept constant) Rs 1,726 +20.6%

Each target takes today’s price of Rs 1,430.60 and scales it by the EPS growth assumed for that case, which is the same as holding the PE multiple constant. The conservative case uses the lower of the FY26 EPS growth and the 4-year EPS CAGR, the base case uses their average and the bull case uses the higher figure. Together they form the Vijaya Diagnostic Centre target price range for the FY27 outlook over the next 12 months, and the range is not a point estimate.

Vijaya Diagnostic Centre Share Price Forecast: What Has to Go Right by 2027

Each Vijaya Diagnostic Centre target price below depends on a specific EPS outcome, and the text states that outcome next to the number.

Conservative Case for the Vijaya Diagnostic Centre Share Price Target: Rs 1,602

Reaching Rs 1,602 needs EPS to rise 11.9% to Rs 20.37 while the stock keeps its current PE multiple. That follows the slower 4-year EPS CAGR of 11.9%.

Base Case for the Vijaya Diagnostic Centre Share Price Target: Rs 1,664

Reaching Rs 1,664 needs EPS to rise 16.3% to Rs 21.16, the average of the FY26 growth rate and the 4-year CAGR. Net profit growth of 37.6% in Q1 FY27 is at or above that pace, which supports the target.

Bull Case for the Vijaya Diagnostic Centre Share Price Target: Rs 1,726

Reaching Rs 1,726 needs EPS to rise 20.6% to Rs 21.95 with the PE multiple held at today’s level. That is above the 52-week high of Rs 1,593.60, so it would need a fresh breakout. A daily close above the nearest resistance level of Rs 1,467.77 (50-day SMA) would be the first technical confirmation.

Vijaya Diagnostic Centre Financial Performance: Revenue, Profit and Margins

Vijaya Diagnostic Centre earned net profit of Rs 172.98 crore on revenue of Rs 835 crore in FY26, with profit up 20.3% and revenue up 19.3% compared with FY25. Diluted EPS was Rs 16.79 against Rs 13.92 a year earlier, and that earnings base anchors the Vijaya Diagnostic Centre share price forecast.

Year Revenue (Rs Cr) Net Profit (Rs Cr) EPS (Rs) Operating Margin Net Margin
FY22 475.20 110.67 10.69 46.83% 23.29%
FY23 473.37 85.21 8.26 42.72% 18.00%
FY24 568.62 119.64 11.59 42.36% 21.04%
FY25 699.71 143.79 13.92 42.63% 20.55%
FY26 835.00 172.98 16.79 43.94% 20.72%

In the latest reported quarter, Q1 FY27 (quarter ended June 2026), revenue was Rs 239.51 crore against Rs 195.10 crore a year earlier (+22.8%), and the bottom line was a net profit of Rs 53.10 crore against a net profit of Rs 38.59 crore (+37.6%). Operating margin was 46.35% versus 42.85% in the year-ago quarter. Cash flow from operations was Rs 270.59 crore in FY26 against Rs 224.47 crore in FY25. Together these figures set the earnings base for the Vijaya Diagnostic Centre share price prediction.

Check the Univest Screener for live Vijaya Diagnostic Centre fundamentals

Is Vijaya Diagnostic Centre Overvalued or Undervalued Right Now?

Vijaya Diagnostic Centre trades at a PE of 78.24 against an industry PE of 62.79, which places the stock at a 24.6% premium to the industry average. The price-to-book ratio is 15.32 on a book value of Rs 92.93 per share. Return on equity of 18.07% means the company earns Rs 18.07 of profit for every Rs 100 of shareholder equity.

Debt to equity is 0.44, so borrowings equal about 44% of shareholder equity. The company declared a dividend of Rs 2.00 per share for FY26, a yield of 0.14% at the current price. This valuation context frames the Vijaya Diagnostic Centre stock price prediction for 2027 without relying on any outside forecast.

Vijaya Diagnostic Centre Stock Analysis: Technical Outlook

Vijaya Diagnostic Centre stock trades below its 50-day SMA of Rs 1,467.77 and above its 200-day EMA of Rs 1,272.57, and the combined daily indicators read mildly bearish. The 52-week high of Rs 1,593.60 was set on 23 September 2026, while the 52-week low of Rs 848.00 came on 30 March 2026.

Indicator Reading Signal
RSI (14) 30.35 Weak momentum
MACD (12,26,9) -10.37 vs signal -0.14 Bearish
ADX (14) 15.86 Weak trend
Supertrend (10,3) Price above Rs 1,391.79 Bullish
50-day SMA Rs 1,467.77 Price below
200-day EMA Rs 1,272.57 Price above

The nearest support level sits at Rs 1,391.79 (Supertrend) and Rs 1,272.57 (200-day EMA). The nearest resistance level sits at Rs 1,467.77 (50-day SMA) and Rs 1,593.60 (52-week high). A sustained move above the nearest resistance would support the Vijaya Diagnostic Centre share price prediction 2027 base case, and this Vijaya Diagnostic Centre stock analysis uses daily candles only. Chart signals add context to the Vijaya Diagnostic Centre share price target without changing the earnings maths.

Vijaya Diagnostic Centre Shareholding Pattern

Promoters hold 52.51% of Vijaya Diagnostic Centre as of Jun 2026, down from 52.63% in Jun 2025 across the last 5 quarters. FII holding is 11.66% (down from 19.56% in Jun 2025) and DII holding is 31.61% (up from 24.07% in Jun 2025), which puts combined institutional holding at 43.27%. Public shareholders own 4.23%. Shareholding data is one input for any Vijaya Diagnostic Centre stock forecast.

Key Risks to the Vijaya Diagnostic Centre Share Price Target for 2027

Earnings and Margin Risk

Operating margin has ranged from 42.36% to 46.83% between FY22 and FY26, so a slip toward the lower end would trim the EPS estimate behind the Vijaya Diagnostic Centre stock forecast. Revenue was up 19.3% in FY26, and slower revenue growth would weigh on the profit path.

Size and Liquidity Risk

Market capitalisation stands at Rs 14,666 crore. Investors should check daily traded volumes and order book depth on NSE before sizing a position, because price moves can be sharper when volumes thin out. Liquidity is a practical constraint on any Vijaya Diagnostic Centre stock price target.

Balance Sheet Risk

Debt to equity of 0.44 means borrowings stand at about 44% of shareholder equity. A rise in borrowing costs or a jump in debt would weigh on profit and on the multiple behind the Vijaya Diagnostic Centre share price forecast.

Technical Risk

The daily indicators read mildly bearish, so the targets above may need a technical turn before the price follows earnings. A daily close below Rs 1,391.79 (Supertrend) would weaken the setup further.

Conclusion

This Vijaya Diagnostic Centre stock analysis puts the share price target range for 2027 at Rs 1,602 to Rs 1,726, with a base case of Rs 1,664 against Rs 1,430.60 today. The inputs are a PE of 78.24 that sits at a 24.6% premium to the industry average, EPS growth of 20.6% in FY26 and a daily technical setup that reads mildly bearish. The next quarterly result will show which scenario is gaining ground. This analysis is educational, so consult a SEBI-registered advisor before acting on it.

Download the Univest iOS App or Univest Android App to track Vijaya Diagnostic Centre live price and get daily stock recommendations.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Vijaya Diagnostic Centre Share Price Prediction 2027

What is the Vijaya Diagnostic Centre share price target for 2027?

Ans. The Vijaya Diagnostic Centre share price forecast for 2027 has a conservative case of Rs 1,602, a base case of Rs 1,664 and a bull case of Rs 1,726. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.

What is the Vijaya Diagnostic Centre share price today?

Ans. Vijaya Diagnostic Centre trades at Rs 1,430.60 on NSE as of 9 October 2026, down 0.03% on the day. The 52-week range is Rs 848.00 to Rs 1,593.60.

Is Vijaya Diagnostic Centre a good stock to buy for 2027?

Ans. The data points in different directions: the PE of 78.24 is at a 24.6% premium to the industry average, EPS grew 20.6% in FY26 and the daily technical setup reads mildly bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.

Can Vijaya Diagnostic Centre stock reach Rs 1,726 in 2027?

Ans. Reaching Rs 1,726 needs EPS to rise 20.6% from Rs 18.20 with the PE multiple held at today’s level, plus a daily close above Rs 1,467.77 (50-day SMA). This is a scenario, not a guarantee.

What are the support and resistance levels for Vijaya Diagnostic Centre?

Ans. The nearest support levels are Rs 1,391.79 (Supertrend) and Rs 1,272.57 (200-day EMA), and the nearest resistance levels are Rs 1,467.77 (50-day SMA) and Rs 1,593.60 (52-week high).

What are the main risks for Vijaya Diagnostic Centre stock in 2027?

Ans. The main risks to the Vijaya Diagnostic Centre share price forecast are a fall in operating margin from the 42.36% to 46.83% range seen since FY22, slower revenue growth after FY26 revenue was up 19.3%, and thin trading volumes. Debt to equity of 0.44 adds balance sheet sensitivity.

How is the Vijaya Diagnostic Centre target price for 2027 calculated?

Ans. Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 11.9% growth, the base case 16.3% and the bull case 20.6%, all drawn from the company’s reported FY26 and 4-year EPS growth.



Healthcare stocks Stock Market
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply